D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
ORIC holding history
Oric Pharmaceuticals, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ORIC overviewAll 13F holders of ORICFull Q2 2026 holdings
- Shares (Q2 2026)
- 1,580,216
- Value
- $17.1M
- % of portfolio
- <0.1%
- Quarters held
- 12
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,580,216 | $17.1M | <0.1% | +1,535,826+3,459.8% | Added | Holders |
| Q1 2026 | 44,390 | $562.4K | <0.1% | +28,368+177.1% | Added | Holders |
| Q4 2025 | 16,022 | $131.1K | <0.1% | +16,022 | New | Holders |
| Q1 2024 | 0 | $0 | 0.0% | −98,433−100.0% | Sold out | Holders |
| Q4 2023 | 98,433 | $905.6K | <0.1% | −209,046−68.0% | Reduced | Holders |
| Q3 2023 | 307,479 | $1.86M | <0.1% | −145,770−32.2% | Reduced | Holders |
| Q2 2023 | 453,249 | $3.52M | <0.1% | −125,054−21.6% | Reduced | Holders |
| Q1 2023 | 578,303 | $3.30M | <0.1% | −24,484−4.1% | Reduced | Holders |
| Q4 2022 | 602,787 | $3.55M | <0.1% | +68,899+12.9% | Added | Holders |
| Q3 2022 | 533,888 | $1.71M | <0.1% | +27,901+5.5% | Added | Holders |
| Q2 2022 | 505,987 | $2.27M | <0.1% | +261,088+106.6% | Added | Holders |
| Q1 2022 | 244,899 | $1.31M | <0.1% | +244,899 | New | Holders |
| Q2 2021 | 0 | $0 | 0.0% | −9,812−100.0% | Sold out | Holders |
| Q1 2021 | 9,812 | $240.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.